España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Abivax
ABVX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.08
0.46
6.04%
At close: -
$8.30
0.22
2.72%
After Hours: Feb 21, 5:42 PM EDT
Get Report
Comment
Abivax (ABVX) Forecast
News
Earnings
Abivax (ABVX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Abivax (NASDAQ:ABVX) Stock
Abivax Stock (NASDAQ: ABVX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 10, 2025
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, January 09, 2025
Abivax Announced A Milestone In The Phase 3 A...
Benzinga Newsdesk
Wednesday, December 04, 2024
This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
JMP Securities Initiates Coverage On Abivax w...
Benzinga Newsdesk
Tuesday, November 19, 2024
Abivax Announced At-The-Market Program To Sel...
Benzinga Newsdesk
Thursday, November 14, 2024
Abivax Q3 Total Principal Debt Outstanding €1...
Benzinga Newsdesk
Thursday, October 03, 2024
Abivax Enrolls First Patient In ENHANCE-CD, P...
Benzinga Newsdesk
Abivax Shares Interim Results On Efficacy And...
Benzinga Newsdesk
Thursday, September 26, 2024
Abivax to Present Ulcerative Colitis Data at ...
Benzinga Newsdesk
Wednesday, September 25, 2024
Abivax Provides Update On Ulcerative Colitis ...
Benzinga Newsdesk
Tuesday, August 06, 2024
ABTECT Phase 3 Trial Hits 600-Patient Milesto...
Benzinga Newsdesk
Monday, July 29, 2024
Laidlaw & Co. Initiates Coverage On Abivax wi...
Benzinga Newsdesk
Monday, July 15, 2024
Abivax Provides Operational And Key Program U...
Benzinga Newsdesk
Monday, June 17, 2024
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Monday, May 20, 2024
BTIG Initiates Coverage On Abivax with Buy Ra...
Benzinga Newsdesk
Wednesday, May 08, 2024
Abivax To Present Four Abstracts For Obefazim...
Benzinga Newsdesk
Monday, April 29, 2024
Abivax shares are trading higher after Guggen...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Abivax with ...
Benzinga Newsdesk
Piper Sandler Initiates Coverage On Abivax wi...
Benzinga Newsdesk
Thursday, April 11, 2024
Morgan Stanley Maintains Equal-Weight on Abiv...
Benzinga Newsdesk
Tuesday, April 02, 2024
Earnings Scheduled For April 2, 2024
Benzinga Insights
Abivax FY23 Net Loss €(147.4)M Down From €(60...
Benzinga Newsdesk
Friday, February 02, 2024
Abivax Announces Modifications To Its Phase 2...
Benzinga Newsdesk
Wednesday, January 24, 2024
Abivax To Host KOL Investor Event To Review P...
Benzinga Newsdesk
Monday, January 22, 2024
Abivax Sets 2024 Strategic Vision with Major ...
Benzinga Newsdesk
Tuesday, November 14, 2023
Leerink Partners Initiates Coverage On Abivax...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Abivax w...
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
